Skip to main content
. 2021 Mar 31;26(6):414–424. doi: 10.1159/000514085

Table 2.

Hearing outcomes at 6-month follow-up in the group RCI

Arm CI (N = 21) (mean ± SD) Arm observation (N = 23) (mean ± SD) p value* CI versus “observation” mean difference adjusted for baseline value, estimations at 6-month follow-up
mean difference 95% CI p value
Speech-in-noise recognition (SNR50 in dB at baseline)
 SpeNbe 3.7±9.7 5.6±9.6
 S0N0 1.4±8.2 1.7±3.8
 SbeNpe −0.6±10 2.2±11.1
Speech-in-noise recognition (SNR50 in dB at 6-month follow-up)
 SpeNbe −1.0±8 2.2±7.9 0.05 −2.35 (−6.59; 1.89) 0.27
 S0N0 −0.9±4.3 0±3.2 0.19 −1.17 (−3.14; 0.80) 0.24
 SbeNpe −3.8±4.5 −3.1±6 0.64 −0.31 (−3.22; 2.61) 0.83
Localization (RMSE in ° at baseline) 73.2±20.7 76.6±20
Localization (RMSE in ° at 6-month follow-up) 63.3±23.4 63.8±19.3 0.80 0.22 (−14.63; 15.07) 0.98

Data are presented as mean ± SD. N, intention-to-treat sample size with 6-month follow-up. CI, cochlear implant; SD, standard deviation; 95% CI, 95% confidence interval; SpeNbe, speech presented to the poor ear and noise to the better ear; SbeNpe, noise presented to the poor ear and speech to the better ear; RCI, randomized for CI; SNR50, signal-to-noise ratio for 50% correct word recognition; S0N0, speech and noise collocated and presented from the loudspeaker in front of the subject; RMSE, root mean square error. * Wilcoxon rank-sum test.

Estimations are obtained from linear regressions adjusted for the baseline value of the outcome, with a robust estimator of the variance.